WHO ICTRP trial
PROSPECTIVE, RANDOMIZED TRIAL OF TICAGRELOR VERSUS PRASUGREL IN PATIENTS WITH…
DRKS00005441 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00005441 |
|---|---|
| Public title | PROSPECTIVE, RANDOMIZED TRIAL OF TICAGRELOR VERSUS PRASUGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME |
| Scientific title | PROSPECTIVE, RANDOMIZED TRIAL OF TICAGRELOR VERSUS PRASUGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME - ISAR-REACT 5 |
| Primary sponsor | Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 4 |
| Countries | Germany;Italy;United States |
| Conditions | I20.0 I21 I24.9;Unstable angina;Acute myocardial infarction;Acute ischaemic heart disease, unspecified;I20.0;I24.9 |
| Interventions | Group 1: Medication therapy with Brilique, substance ticagrelor, tablet 90 mg, oral intake, 2 x / day; duration of therapy: 12 months Group 2: Medication therapy with Efient, substance prasugrel, tablet 10 mg (respectively 5 mg for patients… |
| Registration date | Nov 18, 2013 |
| Target size | 4000 |
| Secondary IDs | NCT01944800;2013-002272-40;GE-IDE-No.00113 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: